refludan and Paraneoplastic-Syndromes

refludan has been researched along with Paraneoplastic-Syndromes* in 1 studies

Other Studies

1 other study(ies) available for refludan and Paraneoplastic-Syndromes

Article	Year
Trousseau's syndrome treated with long-term subcutaneous lepirudin (case report and review of the literature). Journal of thrombosis and thrombolysis, 2001, Volume: 11, Issue:1 We report here a case of recurrent venous and arterial thromboembolism, Trousseau's syndrome, in a cancer patient who developed heparin-induced thrombocytopenia. She was treated with lepirudin and after establishing the patient-specific half-life for subcutaneous lepirudin, she was successfully maintained on this therapy for more than eight months. To our knowledge this case represents the longest reported use of subcutaneous lepirudin. Topics: Anticoagulants; Arterial Occlusive Diseases; Female; Heparin; Hirudins; Humans; Injections, Subcutaneous; Kinetics; Middle Aged; Paraneoplastic Syndromes; Partial Thromboplastin Time; Recombinant Proteins; Recurrence; Thrombocytopenia; Thromboembolism; Venous Thrombosis	2001

Article

Year

Trousseau's syndrome treated with long-term subcutaneous lepirudin (case report and review of the literature).

Journal of thrombosis and thrombolysis, 2001, Volume: 11, Issue:1

We report here a case of recurrent venous and arterial thromboembolism, Trousseau's syndrome, in a cancer patient who developed heparin-induced thrombocytopenia. She was treated with lepirudin and after establishing the patient-specific half-life for subcutaneous lepirudin, she was successfully maintained on this therapy for more than eight months. To our knowledge this case represents the longest reported use of subcutaneous lepirudin.

Topics: Anticoagulants; Arterial Occlusive Diseases; Female; Heparin; Hirudins; Humans; Injections, Subcutaneous; Kinetics; Middle Aged; Paraneoplastic Syndromes; Partial Thromboplastin Time; Recombinant Proteins; Recurrence; Thrombocytopenia; Thromboembolism; Venous Thrombosis

2001